Sponsor Pipeline

Xuanzhu Biopharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
11
Active Trials
3
Recruiting
4
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 4
2
Phase 3
4
Phase 1/2
1
Phase 1
4
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07330531 Drug-drug Interaction Study of Rifampin and Anaprazole Sodium Drug-drug Interaction Study Not Yet Recruiting
NCT07345689 A Study of the Pharmacokinetics and Safety of Anaprazole Sodium in Special Populations Hepatic Insufficiency Not Yet Recruiting
Phase 3
NCT07010107 A Clinical Trial of Anaprazole for Treating Reflux Esophagitis. Reflux Esophagitis (RE) Recruiting
NCT05077449 A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast… Advanced Breast Cancer Active, Not Recruiting
NCT05257395 A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced… Advanced Breast Cancer Active, Not Recruiting
NCT07606833 The Clinical Trail to Evaluate the Efficacy and Safety of Anaprazole Sodium… HELICOBACTER PYLORI INFECTIONS Not Yet Recruiting
Phase 1/2
NCT04996121 A Study of XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally… Locally Advanced or Metastatic Solid Tumors Recruiting
Phase 1
NCT05772455 A Study of XZB-0004 in Patients With Solid Tumors Advanced Solid Tumor Recruiting
NCT05320874 A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. Advanced Solid Tumor Not Yet Recruiting
NCT05766527 A Study of KM602 in Patients With Advanced Solid Tumors Advanced Solid Tumor Not Yet Recruiting
NCT05804864 A Study of KM501 in Patients With Solid Tumors Advanced Solid Tumors Not Yet Recruiting
Disease Areas
Get alerts when Xuanzhu Biopharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free